|
T.TST
|
You might be right Txbioinv. All I know is no management would announced they...
|
|
T.TST
|
Like many TST shareholders, I think our upside potential is limited on the...
|
|
T.TST
|
That link referred to mitomycin C...not the same thing that what you wrote in...
|
|
T.TST
|
Could you please give us a few example of original BLA (with priority review)...
|
|
T.TST
|
Xiamen, Myocyclin is an antiobiotic. It is use/used to treat infections. In...
|
|
T.TST
|
The "disease free survival" rate (which is a time to event endpoint...
|
|
T.TST
|
Just to put TST ' value in context, when a small biotech is taken over by...
|
|
T.TST
|
I'm aware of the number from Doug Loe' latest analysis. But that 188M...
|
|
T.TST
|
Could you please explain us you you get to that number of 180 millions...
|
|
T.TST
|
You have to understand the signification of a "narrow indication"...
|
|
T.TST
|
Because you don't have any clue what will happen by the end of february...
|
|
T.TST
|
If you would have read attentively the info provided in your own link, you...
|
|
T.TST
|
Oh my god, I didn't realize there was a relation between your market cap...
|
|
T.TST
|
Here is my humble opinion on this Superman. First, it is not true that the...
|
|
T.TST
|
According to this study (see links below), the prevalence of BCG intolerant...
|
|
T.TST
|
DY, Officially a drug has to be able to stand on his own feet for the...
|
|
T.TST
|
You're most probably right 13PD. And when we look back in 2014, the...
|
|
T.TST
|
See this news release last week : http://www.ashp.org/menu/DrugShortages...
|
|
T.TST
|
Hey Bio, There is no truth in this (press release announcing an early...
|
|
T.TST
|
Having medical experts from different oncology fields is not a bad thing for...
|